Key result
Biomarkers for nicotine dependence provide future opportunities for precision treatment and inclusion in tobacco cessation and switching clinical trials to advance translation.
Key points are not available for this paper at this time.
Design
Editorial
This editorial provides an overview of a special issue focused on biomarkers for precision treatment of nicotine dependence.
The special issue on Biomarkers of Nicotine and Tobacco Dependence reviews the science for precision treatment of nicotine dependence and future opportunities for research on biomarkers for inclusion in tobacco product cessation and switching clinical trials to advance translation. This overview summarizes the articles contributed to the special issue by leading researcher in field of addiction.
No takes yet. Share an insight, caveat, or question.
Pollock et al. (2023) studied this question. Biomarkers for nicotine dependence provide future opportunities for precision treatment and inclusion in tobacco cessation and switching clinical trials to advance translation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: